7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one

C20H23N9O13P2 — CID 126584741

IUPAC7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one
SMILESNc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c4N=NCC5=O)O[C@@H]3COP(=O)(O)O[C@@H]1[C@@H]2O
InChIInChI=1S/C20H23N9O13P2/c21-16-11-17(23-4-22-16)28(6-25-11)20-15-12(31)8(39-20)2-37-43(33,34)41-14-9(3-38-44(35,36)42-15)40-19(13(14)32)29-5-24-10-7(30)1-26-27-18(10)29/h4-6,8-9,12-15,19-20,31-32H,1-3H2,(H,33,34)(H,35,36)(H2,21,22,23)/t8-,9-,12-,13-,14-,15-,19-,20-/m1/s1
InChIKeySPEXHJHFKYSAMQ-VNQDGEORSA-N
MW659.40 g/mol
LogP-0.88
Rot. Bonds2

About 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one

7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one (PubChem CID 126584741) has the molecular formula C20H23N9O13P2 and a molecular weight of 659.40 g/mol. Its IUPAC name is 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one.

Molecular Properties

Compound Name7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one
PubChem CID126584741
Molecular FormulaC20H23N9O13P2
Molecular Weight659.40 g/mol
Exact Mass659.09
IUPAC Name7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one
SMILESNc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c4N=NCC5=O)O[C@@H]3COP(=O)(O)O[C@@H]1[C@@H]2O
InChIInChI=1S/C20H23N9O13P2/c21-16-11-17(23-4-22-16)28(6-25-11)20-15-12(31)8(39-20)2-37-43(33,34)41-14-9(3-38-44(35,36)42-15)40-19(13(14)32)29-5-24-10-7(30)1-26-27-18(10)29/h4-6,8-9,12-15,19-20,31-32H,1-3H2,(H,33,34)(H,35,36)(H2,21,22,23)/t8-,9-,12-,13-,14-,15-,19-,20-/m1/s1
InChIKeySPEXHJHFKYSAMQ-VNQDGEORSA-N
XLogP-0.88
TPSA299.67 Ų
H-Bond Donors5
H-Bond Acceptors20
Rotatable Bonds2
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500659.40
LogP ≤ 5-0.88
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one?
The IUPAC name of 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one (CID 126584741) is 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one.
What is the SMILES notation for 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one?
The canonical SMILES for 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one is Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c4N=NCC5=O)O[C@@H]3COP(=O)(O)O[C@@H]1[C@@H]2O.
What is the InChIKey of 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one?
The InChIKey is SPEXHJHFKYSAMQ-VNQDGEORSA-N. The full InChI is InChI=1S/C20H23N9O13P2/c21-16-11-17(23-4-22-16)28(6-25-11)20-15-12(31)8(39-20)2-37-43(33,34)41-14-9(3-38-44(35,36)42-15)40-19(13(14)32)29-5-24-10-7(30)1-26-27-18(10)29/h4-6,8-9,12-15,19-20,31-32H,1-3H2,(H,33,34)(H,35,36)(H2,21,22,23)/t8-,9-,12-,13-,14-,15-,19-,20-/m1/s1.
What are the key properties of 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one?
7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one has a molecular weight of 659.40 g/mol, XLogP of -0.88, 2 rotatable bonds, 5 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[(1R,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]-3H-imidazo[4,5-c]pyridazin-4-one is sourced from PubChem (CID 126584741), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).